The MHC class-II and CD44 molecules are involved in the induction of tumour necrosis factor (TNF) gene expression by human monocytes stimulated with tumour cells

1994 ◽  
Vol 56 (2) ◽  
pp. 269-274 ◽  
Author(s):  
Marek Zembala ◽  
Maciej Siedlar ◽  
Irena Ruggiero ◽  
Jerzy Wieckiewicz ◽  
Bozena Mytar ◽  
...  
1995 ◽  
Vol 15 (4) ◽  
pp. 185-193 ◽  
Author(s):  
Marek Jasiński ◽  
Jerzy Wieckiewicz ◽  
Irena Ruggiero ◽  
Anna Pituch-Noworolska ◽  
Marek Zembala

2020 ◽  
Vol 35 (5) ◽  
pp. 1230-1245 ◽  
Author(s):  
L C Poulsen ◽  
J A Bøtkjær ◽  
O Østrup ◽  
K B Petersen ◽  
C Yding Andersen ◽  
...  

Abstract STUDY QUESTION How does the human granulosa cell (GC) transcriptome change during ovulation? SUMMARY ANSWER Two transcriptional peaks were observed at 12 h and at 36 h after induction of ovulation, both dominated by genes and pathways known from the inflammatory system. WHAT IS KNOWN ALREADY The crosstalk between GCs and the oocyte, which is essential for ovulation and oocyte maturation, can be assessed through transcriptomic profiling of GCs. Detailed transcriptional changes during ovulation have not previously been assessed in humans. STUDY DESIGN, SIZE, DURATION This prospective cohort study comprised 50 women undergoing fertility treatment in a standard antagonist protocol at a university hospital-affiliated fertility clinic in 2016–2018. PARTICIPANTS/MATERIALS, SETTING, METHODS From each woman, one sample of GCs was collected by transvaginal ultrasound-guided follicle aspiration either before or 12 h, 17 h or 32 h after ovulation induction (OI). A second sample was collected at oocyte retrieval, 36 h after OI. Total RNA was isolated from GCs and analyzed by microarray. Gene expression differences between the five time points were assessed by ANOVA with a random factor accounting for the pairing of samples, and seven clusters of protein-coding genes representing distinct expression profiles were identified. These were used as input for subsequent bioinformatic analyses to identify enriched pathways and suggest upstream regulators. Subsets of genes were assessed to explore specific ovulatory functions. MAIN RESULTS AND THE ROLE OF CHANCE We identified 13 345 differentially expressed transcripts across the five time points (false discovery rate, <0.01) of which 58% were protein-coding genes. Two clusters of mainly downregulated genes represented cell cycle pathways and DNA repair. Upregulated genes showed one peak at 12 h that resembled the initiation of an inflammatory response, and one peak at 36 h that resembled the effector functions of inflammation such as vasodilation, angiogenesis, coagulation, chemotaxis and tissue remodelling. Genes involved in cell–matrix interactions as a part of cytoskeletal rearrangement and cell motility were also upregulated at 36 h. Predicted activated upstream regulators of ovulation included FSH, LH, transforming growth factor B1, tumour necrosis factor, nuclear factor kappa-light-chain-enhancer of activated B cells, coagulation factor 2, fibroblast growth factor 2, interleukin 1 and cortisol, among others. The results confirmed early regulation of several previously described factors in a cascade inducing meiotic resumption and suggested new factors involved in cumulus expansion and follicle rupture through co-regulation with previously described factors. LARGE SCALE DATA The microarray data were deposited to the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/gds/, accession number: GSE133868). LIMITATIONS, REASONS FOR CAUTION The study included women undergoing ovarian stimulation and the findings may therefore differ from a natural cycle. However, the results confirm significant regulation of many well-established ovulatory genes from a series of previous studies such as amphiregulin, epiregulin, tumour necrosis factor alfa induced protein 6, tissue inhibitor of metallopeptidases 1 and plasminogen activator inhibitor 1, which support the relevance of the results. WIDER IMPLICATIONS OF THE FINDINGS The study increases our understanding of human ovarian function during ovulation, and the publicly available dataset is a valuable resource for future investigations. Suggested upstream regulators and highly differentially expressed genes may be potential pharmaceutical targets in fertility treatment and gynaecology. STUDY FUNDING/COMPETING INTEREST(S) The study was funded by EU Interreg ÔKS V through ReproUnion (www.reprounion.eu) and by a grant from the Region Zealand Research Foundation. None of the authors have any conflicts of interest to declare.


1993 ◽  
Vol 5 (2) ◽  
pp. 141 ◽  
Author(s):  
JS Hunt

Tumour necrosis factor-alpha (TNF), a potent cytokine originally identified as a product of activated macrophages, is now known to be produced by many types of cells, and has been implicated in regulation of normal tissue homeostasis as well as in cellular differentiation. In humans and some murids, the TNF gene is expressed in ovaries, oviducts, uteri, placentas and embryos. Specific transcripts and proteins have been identified in oocytes, granulosa and theca cells, luminal and glandular epithelial cells, myometrial cells, decidual cells, placental trophoblast, macrophage-like cells and embryonic skin. Both prior and subsequent to implantation, uterine TNF mRNA and protein appear in specific cell lineages in an ordered temporal sequence. This and other findings indicate that transcription of the TNF gene in the uterus is regulated either directly or indirectly by ovarian and/or placental hormones. By contrast, there is as yet no evidence for regulation of this gene by other uterine cytokines such as colony stimulating factor-1 (CSF-1). Although the functions of this pleiotrophic, multifunctional molecule are largely unknown, the findings to date are consistent with the postulate that TNF is involved in gamete development, cyclic changes in the uterus, cancers of the female reproductive tract, placental maturation and embryonic development.


2000 ◽  
Vol 15 (12) ◽  
pp. 1928-1934 ◽  
Author(s):  
Akio Nakamura ◽  
Edward James Johns ◽  
Akira Imaizumi ◽  
Yukishige Yanagawa ◽  
Takao Kohsaka

1999 ◽  
Vol 342 (1) ◽  
pp. 21-25 ◽  
Author(s):  
Walter H. WATSON ◽  
Yanming ZHAO ◽  
Rajender K. CHAWLA

Intracellular deficiency of S-adenosylmethionine (AdoMet) and elevated serum concentrations of tumour necrosis factor α (TNF) are hallmarks of toxin-induced liver injury. In these models, the administration of either exogenous AdoMet or antibody/soluble receptor for TNF attenuates the injury. We have demonstrated previously that the administration of exogenous AdoMet to AdoMet-deficient rats attenuated lipopolysaccharide (LPS)-induced liver injury and serum TNF concentrations. Here we report that AdoMet lowered the amount of TNF secreted by LPS-stimulated murine macrophage cells (RAW 264.7) in a dose-dependent manner. The inhibition of TNF release was correlated with changes in the steady-state TNF mRNA concentrations. Changes in TNF mRNA were not due to its altered stability and might have been due to an attenuation of the transcription rate of the TNF gene. The inhibition of TNF release in RAW cells was not mediated by GSH because treatment with AdoMet did not increase intracellular GSH. In addition, N-acetylcysteine, whereas it did increase GSH concentration, had no effect on LPS-stimulated TNF release in these cells. Exogenous AdoMet also attenuated LPS-induced serum TNF levels in normal rats sensitized with lead. Thus AdoMet administration might exert its hepatoprotective effects at least in part by its inhibitory effect on expression of the gene for TNF.


Sign in / Sign up

Export Citation Format

Share Document